Os custos da aterosclerose em Portugal

Bibliographic Details
Main Author: Costa, João
Publication Date: 2021
Other Authors: Alarcão, Joana, Amaral‐Silva, Alexandre, Araújo, Francisco, Ascenção, Raquel, Caldeira, Daniel, Cardoso, Marta Ferreira, Correia, Manuel, Fiorentino, Francesca, Gavina, Cristina, Gil, Victor, Gouveia, Miguel, Lourenço, Francisco, Silva, Alberto Mello e, Pedro, Luís Mendes, Morais, João, Vaz‐Carneiro, António, Veríssimo, Manuel Teixeira, Borges, Margarida
Format: Article
Language: por
Source: Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
Download full: http://hdl.handle.net/10400.14/32195
Summary: Introduction and objectives: Cardiovascular disease is the leading cause of death in Portugal and atherosclerosis is the most common underlying pathophysiological process. The aim of this study was to quantify the economic impact of atherosclerosis in Portugal by estimating disease‐related costs. Methods: Costs were estimated based on a prevalence approach and following a societal perspective. Three national epidemiological sources were used to estimate the prevalence of the main clinical manifestations of atherosclerosis. The annual costs of atherosclerosis included both direct costs (resource consumption) and indirect costs (impact on population productivity). These costs were estimated for 2016, based on data from the Hospital Morbidity Database, the health care database (SIARS) of the Regional Health Administration of Lisbon and Tagus Valley including real‐world data from primary care, the 2014 National Health Interview Survey, and expert opinion. Results: The total cost of atherosclerosis in 2016 reached 1.9 billion euros (58% and 42% of which was direct and indirect costs, respectively). Most of the direct costs were associated with primary care (55%), followed by hospital outpatient care (27%) and hospitalizations (18%). Indirect costs were mainly driven by early exit from the labor force (91%). Conclusions: Atherosclerosis has a major economic impact, being responsible for health expenditure equivalent to 1% of Portuguese gross domestic product and 11% of current health expenditure in 2016.
id RCAP_19b46ecff01e20d6f4ba93e2767b13c7
oai_identifier_str oai:repositorio.ucp.pt:10400.14/32195
network_acronym_str RCAP
network_name_str Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
repository_id_str https://opendoar.ac.uk/repository/7160
spelling Os custos da aterosclerose em PortugalAtherosclerosis: the cost of illness in PortugalAtherosclerosisCost of illnessHealth care costsDirect costsIndirect costsPortugalAteroscleroseCusto da doençaCustos de cuidados de saúdeCustos diretosCustos indiretosPortugalIntroduction and objectives: Cardiovascular disease is the leading cause of death in Portugal and atherosclerosis is the most common underlying pathophysiological process. The aim of this study was to quantify the economic impact of atherosclerosis in Portugal by estimating disease‐related costs. Methods: Costs were estimated based on a prevalence approach and following a societal perspective. Three national epidemiological sources were used to estimate the prevalence of the main clinical manifestations of atherosclerosis. The annual costs of atherosclerosis included both direct costs (resource consumption) and indirect costs (impact on population productivity). These costs were estimated for 2016, based on data from the Hospital Morbidity Database, the health care database (SIARS) of the Regional Health Administration of Lisbon and Tagus Valley including real‐world data from primary care, the 2014 National Health Interview Survey, and expert opinion. Results: The total cost of atherosclerosis in 2016 reached 1.9 billion euros (58% and 42% of which was direct and indirect costs, respectively). Most of the direct costs were associated with primary care (55%), followed by hospital outpatient care (27%) and hospitalizations (18%). Indirect costs were mainly driven by early exit from the labor force (91%). Conclusions: Atherosclerosis has a major economic impact, being responsible for health expenditure equivalent to 1% of Portuguese gross domestic product and 11% of current health expenditure in 2016.VeritatiCosta, JoãoAlarcão, JoanaAmaral‐Silva, AlexandreAraújo, FranciscoAscenção, RaquelCaldeira, DanielCardoso, Marta FerreiraCorreia, ManuelFiorentino, FrancescaGavina, CristinaGil, VictorGouveia, MiguelLourenço, FranciscoSilva, Alberto Mello ePedro, Luís MendesMorais, JoãoVaz‐Carneiro, AntónioVeríssimo, Manuel TeixeiraBorges, Margarida2021-03-15T10:55:53Z20212021-01-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10400.14/32195por0870-255110.1016/j.repc.2020.08.007info:eu-repo/semantics/openAccessreponame:Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)instname:FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologiainstacron:RCAAP2025-03-13T15:00:50Zoai:repositorio.ucp.pt:10400.14/32195Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireinfo@rcaap.ptopendoar:https://opendoar.ac.uk/repository/71602025-05-29T02:09:18.628275Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) - FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologiafalse
dc.title.none.fl_str_mv Os custos da aterosclerose em Portugal
Atherosclerosis: the cost of illness in Portugal
title Os custos da aterosclerose em Portugal
spellingShingle Os custos da aterosclerose em Portugal
Costa, João
Atherosclerosis
Cost of illness
Health care costs
Direct costs
Indirect costs
Portugal
Aterosclerose
Custo da doença
Custos de cuidados de saúde
Custos diretos
Custos indiretos
Portugal
title_short Os custos da aterosclerose em Portugal
title_full Os custos da aterosclerose em Portugal
title_fullStr Os custos da aterosclerose em Portugal
title_full_unstemmed Os custos da aterosclerose em Portugal
title_sort Os custos da aterosclerose em Portugal
author Costa, João
author_facet Costa, João
Alarcão, Joana
Amaral‐Silva, Alexandre
Araújo, Francisco
Ascenção, Raquel
Caldeira, Daniel
Cardoso, Marta Ferreira
Correia, Manuel
Fiorentino, Francesca
Gavina, Cristina
Gil, Victor
Gouveia, Miguel
Lourenço, Francisco
Silva, Alberto Mello e
Pedro, Luís Mendes
Morais, João
Vaz‐Carneiro, António
Veríssimo, Manuel Teixeira
Borges, Margarida
author_role author
author2 Alarcão, Joana
Amaral‐Silva, Alexandre
Araújo, Francisco
Ascenção, Raquel
Caldeira, Daniel
Cardoso, Marta Ferreira
Correia, Manuel
Fiorentino, Francesca
Gavina, Cristina
Gil, Victor
Gouveia, Miguel
Lourenço, Francisco
Silva, Alberto Mello e
Pedro, Luís Mendes
Morais, João
Vaz‐Carneiro, António
Veríssimo, Manuel Teixeira
Borges, Margarida
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Veritati
dc.contributor.author.fl_str_mv Costa, João
Alarcão, Joana
Amaral‐Silva, Alexandre
Araújo, Francisco
Ascenção, Raquel
Caldeira, Daniel
Cardoso, Marta Ferreira
Correia, Manuel
Fiorentino, Francesca
Gavina, Cristina
Gil, Victor
Gouveia, Miguel
Lourenço, Francisco
Silva, Alberto Mello e
Pedro, Luís Mendes
Morais, João
Vaz‐Carneiro, António
Veríssimo, Manuel Teixeira
Borges, Margarida
dc.subject.por.fl_str_mv Atherosclerosis
Cost of illness
Health care costs
Direct costs
Indirect costs
Portugal
Aterosclerose
Custo da doença
Custos de cuidados de saúde
Custos diretos
Custos indiretos
Portugal
topic Atherosclerosis
Cost of illness
Health care costs
Direct costs
Indirect costs
Portugal
Aterosclerose
Custo da doença
Custos de cuidados de saúde
Custos diretos
Custos indiretos
Portugal
description Introduction and objectives: Cardiovascular disease is the leading cause of death in Portugal and atherosclerosis is the most common underlying pathophysiological process. The aim of this study was to quantify the economic impact of atherosclerosis in Portugal by estimating disease‐related costs. Methods: Costs were estimated based on a prevalence approach and following a societal perspective. Three national epidemiological sources were used to estimate the prevalence of the main clinical manifestations of atherosclerosis. The annual costs of atherosclerosis included both direct costs (resource consumption) and indirect costs (impact on population productivity). These costs were estimated for 2016, based on data from the Hospital Morbidity Database, the health care database (SIARS) of the Regional Health Administration of Lisbon and Tagus Valley including real‐world data from primary care, the 2014 National Health Interview Survey, and expert opinion. Results: The total cost of atherosclerosis in 2016 reached 1.9 billion euros (58% and 42% of which was direct and indirect costs, respectively). Most of the direct costs were associated with primary care (55%), followed by hospital outpatient care (27%) and hospitalizations (18%). Indirect costs were mainly driven by early exit from the labor force (91%). Conclusions: Atherosclerosis has a major economic impact, being responsible for health expenditure equivalent to 1% of Portuguese gross domestic product and 11% of current health expenditure in 2016.
publishDate 2021
dc.date.none.fl_str_mv 2021-03-15T10:55:53Z
2021
2021-01-01T00:00:00Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10400.14/32195
url http://hdl.handle.net/10400.14/32195
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv 0870-2551
10.1016/j.repc.2020.08.007
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.source.none.fl_str_mv reponame:Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
instname:FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
instacron:RCAAP
instname_str FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
instacron_str RCAAP
institution RCAAP
reponame_str Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
collection Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
repository.name.fl_str_mv Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) - FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
repository.mail.fl_str_mv info@rcaap.pt
_version_ 1833601248683622400